Application Type
Patent
Application SubType
PCT National Phase
(10) Registration Number and Date
BNN20190088 12.12.2022
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
BN N/2019/0088 16.01.2018
(40) Publication Number and Date
BN N/2019/0088
A
12.12.2022
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
(85) National Entry Date
(30) Priority Details
US 62/447,057
17.01.2017
(51) IPC Classes
(71/73) Applicant
(72) Inventor
(EN) NILSSON, Karl, Magnus : AstraZeneca 431 83 Mölndal
(EN) ÅSTRAND, Annika, Birgitta, Margareta : AstraZeneca 431 83 Mölndal
(EN) BERGGREN, Anna, Ingrid, Kristina : AstraZeneca 431 83 Mölndal
(EN) JOHANSSON, Johan, R. : AstraZeneca 431 83 Mölndal
(EN) LEPISTÖ, Matti, Juhani : AstraZeneca 431 83 Mölndal
(EN) KAWATKAR, Sameer, Pralhad : Astrazeneca Pharmaceuticals LP, 1800 Concord Pike Wilmington, DE 19803
(EN) SU, Qibin : Astrazeneca Pharmaceuticals LP, 1800 Concord Pike Wilmington, DE 19803
(74) Representative Name
(EN) Ahmad Isa & Partners : Unit Nos. 404A-410A 4th Floor, Wisma Jaya Jalan Pemancha Bandar Seri Begawan BS8811
(54) Title
(EN) JAK1 SELECTIVE INHIBITORS
(57) Abstract
(EN) --
Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein R1-R8 have any of the meanings defined herein. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of using the same.
(58) Citations